Header Logo

Connection

CRAIG LOGSDON to Drug Design

Back to Details
This is a "connection" page, showing publications CRAIG LOGSDON has written about Drug Design.
CRAIG LOGSDON
Connection Strength
0.165
Drug Design
  1. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy. Mol Cancer Ther. 2013 May; 12(5):654-62.
    View in: PubMed
    Score: 0.090
  2. S100P: a novel therapeutic target for cancer. Amino Acids. 2011 Oct; 41(4):893-9.
    View in: PubMed
    Score: 0.075
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.